|
Volumn 7, Issue 2, 2001, Pages 163-168
|
Enhancement of the antiproliferative function of p53 by phosphorylation at serine 20: an inference from site-directed mutagenesis studies.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CDKN1A PROTEIN, HUMAN;
CYCLIN DEPENDENT KINASE INHIBITOR 1A;
CYCLINE;
ENZYME INHIBITOR;
MDM2 PROTEIN, HUMAN;
NUCLEAR PROTEIN;
ONCOPROTEIN;
PROTEIN MDM2;
PROTEIN P53;
SERINE;
AMINO ACID SUBSTITUTION;
ARTICLE;
CELL DIVISION;
CELL STRAIN K 562;
DNA DAMAGE;
DRUG EFFECT;
DRUG STABILITY;
GENETIC TRANSFECTION;
GENETICS;
HUMAN;
METABOLISM;
PHOSPHORYLATION;
PHYSIOLOGY;
PROTEIN BINDING;
RADIATION EXPOSURE;
SITE DIRECTED MUTAGENESIS;
TRANSACTIVATION;
AMINO ACID SUBSTITUTION;
CELL DIVISION;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
CYCLINS;
DNA DAMAGE;
DRUG STABILITY;
ENZYME INHIBITORS;
HUMANS;
K562 CELLS;
MUTAGENESIS, SITE-DIRECTED;
NUCLEAR PROTEINS;
PHOSPHORYLATION;
PROTEIN BINDING;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-MDM2;
SERINE;
TRANS-ACTIVATION (GENETICS);
TRANSFECTION;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 0035258591
PISSN: 11073756
EISSN: None
Source Type: Journal
DOI: 10.3892/ijmm.7.2.163 Document Type: Article |
Times cited : (12)
|
References (0)
|